September 17, 2021

Insights and Strategies for Successful Development of Scalable AAV Processes: Part 2 of 2

Click here to view more Industry Leader Q&As >>

In the second of a two-part series, Anki Magnusson, Staff Research Engineer, Protein and Viral Production, and Åsa Hagner-McWhirter, PhD, Senior Scientist, Bioprocess Applications R&D, both at Cytiva, discuss upstream and downstream strategies for successful adeno-associated virus (AAV) production.

Topics covered include:

1:00 – The upstream approach for AAV production, such as finding the balance between different parameters in the design of experiments to create a robust production process

4:00 – Three strategies for the downstream aspects of successful AAV production, which include starting out with good upstream material and optimizing conditions appropriately

6:35 – Upcoming solutions for AAV processing

Learn more about AAV production:
Webinar on demand: Start-to-finish AAV production 

AAV resources hub

Tags: downstream, upstream, process development, AAV